MedPath

Efficacy of Diode Laser in Peri-implantitis

Not Applicable
Completed
Conditions
Alveolar Bone Loss
Implant
Complications
Peri-Implantitis
Interventions
Device: DL application in peri-implantitis
Procedure: Conventional peri-implantitis treatment
Registration Number
NCT02362854
Lead Sponsor
Istanbul University
Brief Summary

The aim of this study was to compare the efficacy of a diode laser (DL) as an adjunct to conventional scaling in the treatment of mild-to-moderate peri-implantitis. A prospective clinical, radiographic and microbiologic split-mouth study was conducted to test the following null hypothesis; adjunct application of a diode laser, in the conventional treatment of peri-implantitis, are not associated with a statistically significant difference regarding the microbial counts, marginal bone loss and peri-implant parameters.

Detailed Description

Efficacy of a diode laser (DL) in peri-implantitis was investigated. 48 implants diagnosed with peri-implantitis were included. In addition to the conventional scaling and debridement, random 24 implants were lased by a DL. Periodontal indexes, microbiologic specimens and radiographs were used for assessment. Baseline parameters were similar between groups. After six months laser group revealed higher MBL than the control group. Microbiota of the implants were found unchanged after one month. DL appears to have no additional positive influence on the peri-implantitis treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • 18 years and older
  • No local and systemic health problems prohibit the study interventions
  • Bi-lateral implants with peri-implantitis diagnosis
Exclusion Criteria
  • Local and systemic health problems prohibiting the study interventions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DL application in peri-implantitisDL application in peri-implantitisAdjunct Diode Laser application.
Conventional peri-implantitis treatmentConventional peri-implantitis treatmentPeri-implantitis treatment according to the Cumulative interceptive supportive (CIST) therapy.
Primary Outcome Measures
NameTimeMethod
Bacterial countsOne month

Bacterial load around the the diseased implants will be determined at the initiation of the study. The assessment will be performed after one months

Secondary Outcome Measures
NameTimeMethod
Marginal Bone lossSix months

The marginal bone loss around the diseased implants will be assessed after six months to analyse any bone level change.

Trial Locations

Locations (1)

Department of Oral Implantology, Faculty of Dentistry, Istanbul University

🇹🇷

Istanbul, Capa, Turkey

© Copyright 2025. All Rights Reserved by MedPath